Costantino Maria, Conti Valeria, Corbi Graziamaria, Filippelli Amelia
Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Via S. Allende, 84081 Baronissi, Italy.
Association Non-Profit F.I.R.S.Thermae (Interdisciplinary Training, Researches and Spa Sciences) in Italian National Register of Research of MIUR, 80078 Pozzuoli, Italy.
Antioxidants (Basel). 2021 Nov 5;10(11):1773. doi: 10.3390/antiox10111773.
Hydropinotherapy is a salus per aquam (Spa) treatment suitable as a complementary approach to treat several diseases, which strongly affect the quality of life (QoL). Hydropinotherapy with sulphurous mineral water exerts benefits thanks to components, such as hydrogen sulphide, which is considered mainly responsible for antioxidant and hypoglycaemic effects. Such properties, linked from each other, could favour an improvement in patients' QoL. However, data on humans are scarce. This study aimed to investigate whether a cycle of sulphurous hydropinotherapy was able to modify plasma levels of glucose and reactive oxygen metabolites (ROMs) and improve QoL in patients suffering from several chronic disorders. A prospective, observational study involved patients with gastrointestinal diseases who received a prescription of a cycle of sulphurous hydropinotherapy (S-HT). Age- and sex-matched control group was enrolled (No S-HT). Glycaemia and plasma concentration of ROMs were measured in all subjects. The impact of spa treatment on the QoL was assessed using the Short Form 36 Health Status Survey questionnaire (SF-36). All parameters were measured at baseline and at the end of a 2-week treatment. Between the groups, no differences were found in glycaemia and ROMs at baseline. In the S-HT group, a reduction in glycaemia and ROMs, both in respect to baseline ( = 0.005 and = 0.031, respectively) and to control group, as shown by the delta value calculated, as the difference between the values at 2 weeks and baseline ( = 0.0009 and = 0.0001, respectively). In the S-HT, delta ROMs was the best predictor of delta glycaemia with a direct linear correlation (beta = 0.559, 95% CI 0.471 to 0.647, < 0.0001). In the S-HT, the SF-36 total score was improved both when compared with baseline ( = 0.002) and with No S-HT ( = 0.001). Sulphurous hydropinotherapy induces a decrease in glycaemia and ROM levels, also ameliorating the patients' QoL. Therefore, it could be considered a useful complementary therapeutic approach.
水针疗法是一种水疗(温泉疗法),适合作为治疗几种严重影响生活质量(QoL)疾病的辅助方法。含硫矿泉水水针疗法因其成分(如硫化氢)而发挥作用,硫化氢被认为是抗氧化和降血糖作用的主要原因。这些相互关联的特性可能有助于改善患者的生活质量。然而,关于人体的数据很少。本研究旨在调查含硫水针疗法周期是否能够改变患有多种慢性疾病患者的血糖和活性氧代谢产物(ROMs)水平,并改善其生活质量。一项前瞻性观察性研究纳入了接受含硫水针疗法(S-HT)周期处方的胃肠道疾病患者。设立年龄和性别匹配的对照组(无S-HT)。测量所有受试者的血糖和ROMs血浆浓度。使用简短健康调查问卷(SF-36)评估水疗对生活质量的影响。所有参数在基线和为期2周的治疗结束时进行测量。两组之间,基线时血糖和ROMs无差异。在S-HT组中,血糖和ROMs均较基线水平降低(分别为P = 0.005和P = 0.031),与对照组相比也降低,通过计算2周时与基线值的差值(delta值)显示(分别为P = 0.0009和P = 0.0001)。在S-HT组中,delta ROMs是delta血糖的最佳预测指标,呈直接线性相关(β = 0.559,95%CI 0.471至0.647,P < 0.0001)。在S-HT组中,与基线相比(P = 0.002)以及与无S-HT组相比(P = 0.001),SF-36总分均有所改善。含硫水针疗法可降低血糖和ROM水平,同时改善患者的生活质量。因此,它可被视为一种有用的辅助治疗方法。